Exhibit 99.2

             VCA Antech, Inc. Updates Guidance for Fiscal Year 2006

     LOS ANGELES--(BUSINESS WIRE)--Oct. 25, 2006--VCA Antech, Inc.
(NASDAQ:WOOF), a leading animal healthcare company in the United States,
provides the following revised financial guidance for all investors in adherence
with Regulation Fair Disclosure as issued by the United States Securities and
Exchange Commission, the SEC. We encourage all current and potential investors
to review the disclosure regarding forward-looking statements in this press
release as well as in all financial documents filed with the SEC.

     We are providing revised financial guidance for the year ending December
31, 2006 as follows:

     --   Revenue of $968 million to $975 million;

     --   Diluted earnings per common share of $1.21 to $1.22; and

     --   Adjusted diluted earnings per common share of $1.13 to $1.14, which
          excludes a tax benefit of $0.08 per diluted common share as described
          above.

     Non-GAAP Financial Measures

     We believe investors' understanding of our total performance is enhanced by
disclosing adjusted net income and adjusted diluted earnings per common share.
We define adjusted net income and adjusted diluted earnings per common share as
the reported items, adjusted to exclude certain significant items. Adjusted
diluted earnings per common share is adjusted net income divided by diluted
common shares outstanding.

     Management uses adjusted net income and adjusted diluted earnings per
common share because they exclude the effect of significant items that we
believe are not representative of our core operations for the periods presented.
As a result, these non-GAAP financial measures help to provide meaningful
comparisons of our overall performance from one reporting period to another and
meaningful assessments of our future performance and related trends. For the
guidance provided above, the only item excluded in computing adjusted net income
and adjusted diluted earnings per common share was a $6.8 million tax benefit
recorded in the first quarter of 2006.

     There is a material limitation associated with the use of these non-GAAP
financial measures: our computation of adjusted net income excludes the impact
of certain items and as a result, our computation of adjusted diluted earnings
per common share does not depict diluted earnings per common share in accordance
with GAAP.

     To compensate for the limitations in the non-GAAP financial measures
discussed above, our disclosures provide a complete understanding of all
adjustments found in non-GAAP financial measures, and we reconcile the non-GAAP
financial measures to the GAAP financial measures in the following table (in
millions, except earnings per common share):


                                                      Year Ending
                                                   December 31, 2006
                                                 ---------------------
Diluted earnings per common share                    $1.21      $1.22
Tax benefit                                          (0.08)     (0.08)
                                                 ---------- ----------
   Adjusted diluted earnings per common share        $1.13      $1.14
                                                 ========== ==========


     Forward-Looking Statements

     This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995, including our financial
guidance for fiscal year 2006. Among the important factors that could cause
actual results to differ are: a material adverse change in our financial
condition or operations; the rate of our laboratory internal revenue growth and
animal hospital same-store revenue growth; the level of direct costs and our
ability to maintain revenue at a level necessary to maintain expected operating
margins; the level of selling, general and administrative costs; the effects of
our recent acquisitions, including Pet's Choice, Inc., and our ability to
effectively manage our growth and achieve operating synergies; a continued
decline in demand for some of our products and services; any disruption in our
information technology systems or transportation networks; the effects of
competition; any impairment in the carrying value of our goodwill; changes in
prevailing interest rates; our ability to service our debt; and general economic
conditions. These and other risk factors are discussed in our Report on Form
10-K for the year ended December 31, 2005 and our Report on Form 10-Q for the
quarter ended June 30, 2006, and the reader is directed to these statements for
a further discussion of important factors that could cause actual results to
differ materially from those in the forward-looking statements.

     We own, operate and manage the largest networks of freestanding veterinary
hospitals and veterinary-exclusive clinical laboratories in the country, and we
supply ultrasound and digital radiography equipment to the veterinary industry.


     CONTACT: VCA Antech, Inc.
              Tomas Fuller, 310-571-6505
              Chief Financial Officer